Immuno-C: Filed IND; expects to start Phase I trial in 25 healthy volunteers, testing dose and measuring how much crosses from gut into the bloodstream

Biomune Systems Inc. (BIMED), Salt

Read the full 55 word article

How to gain access

Continue reading with a
two-week free trial.